Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 3 | 2023 | 22 | 2.180 |
Why?
|
| Neuroma, Acoustic | 6 | 2022 | 10 | 2.140 |
Why?
|
| Cochlear Implants | 3 | 2023 | 30 | 2.140 |
Why?
|
| Tinnitus | 6 | 2019 | 12 | 2.030 |
Why?
|
| Vestibule, Labyrinth | 3 | 2022 | 6 | 1.800 |
Why?
|
| Otosclerosis | 8 | 2021 | 8 | 1.510 |
Why?
|
| Ear, Middle | 4 | 2019 | 8 | 1.490 |
Why?
|
| Stapes Surgery | 8 | 2021 | 8 | 1.380 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2023 | 16 | 1.100 |
Why?
|
| Postoperative Complications | 9 | 2021 | 997 | 1.030 |
Why?
|
| Ear Neoplasms | 2 | 2015 | 6 | 0.970 |
Why?
|
| Internship and Residency | 2 | 2018 | 227 | 0.960 |
Why?
|
| Hydroxyapatites | 3 | 2020 | 9 | 0.930 |
Why?
|
| Neurilemmoma | 2 | 2022 | 17 | 0.920 |
Why?
|
| Otolaryngology | 3 | 2020 | 34 | 0.890 |
Why?
|
| Otologic Surgical Procedures | 4 | 2017 | 4 | 0.850 |
Why?
|
| Speech Perception | 1 | 2023 | 47 | 0.850 |
Why?
|
| Humans | 48 | 2023 | 31070 | 0.820 |
Why?
|
| Retrospective Studies | 23 | 2023 | 3665 | 0.750 |
Why?
|
| Craniotomy | 2 | 2019 | 29 | 0.730 |
Why?
|
| Bone Cements | 2 | 2020 | 95 | 0.720 |
Why?
|
| Endoscopy | 2 | 2018 | 199 | 0.690 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 1 | 2019 | 1 | 0.680 |
Why?
|
| Dizziness | 1 | 2019 | 20 | 0.670 |
Why?
|
| Temporal Bone | 2 | 2017 | 12 | 0.650 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2022 | 26 | 0.620 |
Why?
|
| Ear, Inner | 3 | 2019 | 4 | 0.600 |
Why?
|
| Malleus | 1 | 2017 | 1 | 0.600 |
Why?
|
| Skull | 1 | 2017 | 26 | 0.570 |
Why?
|
| Stapedius | 1 | 2017 | 1 | 0.570 |
Why?
|
| Treatment Outcome | 16 | 2023 | 3809 | 0.570 |
Why?
|
| Vascular Malformations | 1 | 2017 | 4 | 0.570 |
Why?
|
| Incidental Findings | 1 | 2017 | 19 | 0.560 |
Why?
|
| Ear Canal | 2 | 2022 | 4 | 0.550 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 240 | 0.550 |
Why?
|
| Cartilage | 1 | 2017 | 159 | 0.550 |
Why?
|
| Male | 26 | 2021 | 16499 | 0.530 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 135 | 0.520 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 4 | 0.510 |
Why?
|
| Microsurgery | 2 | 2015 | 45 | 0.510 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 60 | 0.510 |
Why?
|
| Middle Aged | 22 | 2021 | 10239 | 0.510 |
Why?
|
| Exostoses | 1 | 2015 | 1 | 0.500 |
Why?
|
| Stroke | 1 | 2019 | 315 | 0.500 |
Why?
|
| Osteoma | 1 | 2015 | 5 | 0.500 |
Why?
|
| Microscopy | 1 | 2015 | 10 | 0.490 |
Why?
|
| Lighting | 1 | 2015 | 16 | 0.490 |
Why?
|
| Adult | 21 | 2021 | 8949 | 0.480 |
Why?
|
| Meniere Disease | 3 | 2021 | 3 | 0.480 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2014 | 1 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 818 | 0.480 |
Why?
|
| Eyeglasses | 1 | 2014 | 3 | 0.480 |
Why?
|
| Eye Movements | 1 | 2014 | 20 | 0.470 |
Why?
|
| Physician's Role | 1 | 2014 | 18 | 0.460 |
Why?
|
| Adenoma | 1 | 2014 | 46 | 0.450 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 120 | 0.440 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2012 | 1 | 0.430 |
Why?
|
| Eustachian Tube | 2 | 2019 | 4 | 0.420 |
Why?
|
| Biomarkers | 1 | 2016 | 733 | 0.410 |
Why?
|
| Female | 25 | 2021 | 17018 | 0.410 |
Why?
|
| Acoustic Impedance Tests | 1 | 2011 | 1 | 0.380 |
Why?
|
| Hearing Loss | 2 | 2021 | 13 | 0.380 |
Why?
|
| Reoperation | 6 | 2021 | 952 | 0.370 |
Why?
|
| Hearing Loss, Sudden | 1 | 2010 | 1 | 0.370 |
Why?
|
| Heroin | 1 | 2010 | 2 | 0.370 |
Why?
|
| Hearing Aids | 1 | 2010 | 3 | 0.370 |
Why?
|
| Aged | 17 | 2020 | 10079 | 0.360 |
Why?
|
| Triage | 1 | 2010 | 23 | 0.350 |
Why?
|
| Family Practice | 1 | 2010 | 20 | 0.350 |
Why?
|
| Cerebellopontine Angle | 2 | 2020 | 5 | 0.350 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 408 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 344 | 0.300 |
Why?
|
| Stapes | 3 | 2021 | 3 | 0.280 |
Why?
|
| Hearing | 3 | 2021 | 23 | 0.280 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 5192 | 0.270 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 76 | 0.260 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2022 | 2 | 0.260 |
Why?
|
| Encephalocele | 2 | 2022 | 32 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 1314 | 0.250 |
Why?
|
| Tympanic Membrane | 2 | 2017 | 4 | 0.250 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2015 | 6 | 0.240 |
Why?
|
| Adolescent | 7 | 2021 | 2403 | 0.240 |
Why?
|
| Tympanic Membrane Perforation | 2 | 2021 | 3 | 0.240 |
Why?
|
| Endolymphatic Sac | 1 | 2004 | 2 | 0.240 |
Why?
|
| Databases as Topic | 1 | 2023 | 17 | 0.230 |
Why?
|
| Facial Nerve | 3 | 2020 | 13 | 0.210 |
Why?
|
| Radiosurgery | 2 | 2020 | 38 | 0.210 |
Why?
|
| Cranial Fossa, Middle | 1 | 2022 | 8 | 0.210 |
Why?
|
| Cochlea | 1 | 2022 | 2 | 0.210 |
Why?
|
| Mastoidectomy | 1 | 2022 | 1 | 0.200 |
Why?
|
| Ossicular Prosthesis | 2 | 2020 | 2 | 0.200 |
Why?
|
| Mastoid | 3 | 2022 | 3 | 0.190 |
Why?
|
| Ossicular Replacement | 1 | 2020 | 1 | 0.190 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 8 | 0.190 |
Why?
|
| Facial Paralysis | 1 | 2020 | 9 | 0.180 |
Why?
|
| Anesthesia, General | 1 | 2020 | 30 | 0.180 |
Why?
|
| Arteries | 1 | 2020 | 20 | 0.180 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2020 | 9 | 0.180 |
Why?
|
| Urban Health Services | 1 | 2020 | 14 | 0.180 |
Why?
|
| Patient Care Team | 2 | 2014 | 152 | 0.180 |
Why?
|
| Ear Diseases | 1 | 2019 | 3 | 0.170 |
Why?
|
| Young Adult | 5 | 2020 | 2063 | 0.170 |
Why?
|
| Brain Abscess | 1 | 2019 | 7 | 0.170 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 162 | 0.170 |
Why?
|
| Tuberculosis | 1 | 2019 | 25 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 420 | 0.170 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 6 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 126 | 0.160 |
Why?
|
| Quality of Life | 1 | 2004 | 696 | 0.160 |
Why?
|
| Skull Base | 1 | 2019 | 32 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 89 | 0.160 |
Why?
|
| Telemedicine | 1 | 2020 | 112 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 101 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 135 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 104 | 0.150 |
Why?
|
| Sepsis | 1 | 2019 | 154 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 88 | 0.150 |
Why?
|
| Patient Selection | 1 | 2019 | 246 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2020 | 453 | 0.140 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2021 | 11 | 0.140 |
Why?
|
| Child | 4 | 2021 | 1431 | 0.140 |
Why?
|
| Cadaver | 1 | 2017 | 380 | 0.130 |
Why?
|
| Risk Factors | 4 | 2021 | 2593 | 0.130 |
Why?
|
| Chemokines | 1 | 2016 | 29 | 0.130 |
Why?
|
| Vestibular Function Tests | 1 | 2015 | 2 | 0.130 |
Why?
|
| Hearing Disorders | 1 | 2015 | 2 | 0.130 |
Why?
|
| Semicircular Canals | 1 | 2015 | 7 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 230 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 586 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 80 | 0.130 |
Why?
|
| Endometrium | 1 | 2015 | 6 | 0.130 |
Why?
|
| Hemifacial Spasm | 1 | 2014 | 2 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2015 | 37 | 0.120 |
Why?
|
| Burns | 1 | 2015 | 23 | 0.120 |
Why?
|
| Melanoma | 1 | 2015 | 54 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 67 | 0.120 |
Why?
|
| Nerve Compression Syndromes | 1 | 2014 | 27 | 0.120 |
Why?
|
| United States | 2 | 2018 | 2375 | 0.120 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2013 | 1 | 0.120 |
Why?
|
| Vestibular Nerve | 1 | 2013 | 3 | 0.110 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2013 | 4 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 114 | 0.110 |
Why?
|
| Rotation | 1 | 2014 | 142 | 0.110 |
Why?
|
| Placebo Effect | 1 | 2014 | 24 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1133 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 206 | 0.110 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 61 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2014 | 91 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2014 | 534 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 151 | 0.110 |
Why?
|
| Gentamicins | 2 | 2002 | 16 | 0.100 |
Why?
|
| Anxiety | 1 | 2014 | 156 | 0.100 |
Why?
|
| HIV Infections | 1 | 2019 | 890 | 0.100 |
Why?
|
| Hearing Loss, Conductive | 2 | 2021 | 3 | 0.100 |
Why?
|
| Comorbidity | 1 | 2014 | 508 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 387 | 0.100 |
Why?
|
| Bone Conduction | 2 | 2021 | 2 | 0.100 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 9 | 0.100 |
Why?
|
| Auditory Threshold | 1 | 2010 | 16 | 0.090 |
Why?
|
| Drug Overdose | 1 | 2010 | 8 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2011 | 118 | 0.090 |
Why?
|
| Meditation | 1 | 2010 | 11 | 0.090 |
Why?
|
| Auditory Perception | 1 | 2010 | 36 | 0.090 |
Why?
|
| Respiration | 1 | 2010 | 35 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2010 | 51 | 0.090 |
Why?
|
| Tympanoplasty | 2 | 2017 | 3 | 0.090 |
Why?
|
| Depression | 1 | 2014 | 481 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 108 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 691 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2010 | 254 | 0.070 |
Why?
|
| Time Factors | 2 | 2020 | 1681 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 2045 | 0.060 |
Why?
|
| Round Window, Ear | 1 | 2002 | 1 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2004 | 429 | 0.050 |
Why?
|
| Labyrinthine Fluids | 1 | 2002 | 1 | 0.050 |
Why?
|
| Otitis Media | 1 | 2002 | 5 | 0.050 |
Why?
|
| Incus | 1 | 2021 | 1 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 818 | 0.050 |
Why?
|
| Contraindications | 1 | 2021 | 42 | 0.050 |
Why?
|
| Granuloma | 1 | 2021 | 15 | 0.050 |
Why?
|
| Tertiary Healthcare | 1 | 2020 | 2 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1801 | 0.040 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 22 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 41 | 0.040 |
Why?
|
| South Africa | 1 | 2019 | 19 | 0.040 |
Why?
|
| Myoclonus | 1 | 2019 | 24 | 0.040 |
Why?
|
| Neuroma | 1 | 2019 | 4 | 0.040 |
Why?
|
| Facial Neoplasms | 1 | 2019 | 4 | 0.040 |
Why?
|
| Meningioma | 1 | 2019 | 20 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 16 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 1209 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 76 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 74 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 274 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 65 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 551 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2017 | 165 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 354 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2017 | 132 | 0.030 |
Why?
|
| GATA2 Transcription Factor | 1 | 2015 | 1 | 0.030 |
Why?
|
| Transcription Factor AP-2 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2015 | 3 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 28 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 34 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 45 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 19 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 53 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 66 | 0.030 |
Why?
|
| Neuromuscular Agents | 1 | 2014 | 20 | 0.030 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2014 | 35 | 0.030 |
Why?
|
| Electromyography | 1 | 2014 | 78 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 111 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2015 | 152 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 305 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 405 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 57 | 0.010 |
Why?
|
| Fascia | 1 | 2002 | 9 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 691 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 1898 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 1935 | 0.010 |
Why?
|